Insider Transactions in Q1 2024 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 06
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
7,983
-12.16%
|
-
|
|
Feb 06
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+21.52%
|
-
|
|
Feb 06
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
16,450
-7.95%
|
-
|
|
Feb 06
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Grant, award, or other acquisition
|
Direct |
33,332
+13.88%
|
-
|
|
Feb 06
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
11,579
-30.65%
|
-
|
|
Feb 06
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+34.62%
|
-
|
|
Feb 06
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
65,047
-3.82%
|
-
|
|
Feb 06
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
146,666
+7.94%
|
-
|
|
Feb 06
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
12,160
-14.61%
|
-
|
|
Feb 06
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Grant, award, or other acquisition
|
Direct |
26,666
+24.26%
|
-
|
|
Feb 06
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
5,472
-10.36%
|
-
|
|
Feb 06
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+18.52%
|
-
|
|
Jan 12
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
11,660
-6.3%
|
$699,600
$60.0 P/Share
|
|
Jan 09
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
15,172
-21.14%
|
$895,148
$59.25 P/Share
|
|
Jan 09
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
15,172
+17.45%
|
$242,752
$16.31 P/Share
|
|
Jan 04
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
15,000
-20.95%
|
$870,000
$58.4 P/Share
|
|
Jan 04
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+17.32%
|
$240,000
$16.31 P/Share
|
|
Jan 03
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
11,931
-17.41%
|
$680,067
$57.82 P/Share
|
|
Jan 01
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,199
-3.28%
|
$467,343
$57.81 P/Share
|
|
Jan 01
2024
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,979
+8.75%
|
-
|
|
Jan 01
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
6,733
-30.89%
|
$383,781
$57.81 P/Share
|
|
Jan 01
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
14,823
+40.47%
|
-
|
|
Jan 01
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
5,380
-10.14%
|
$306,660
$57.81 P/Share
|
|
Jan 01
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
11,772
+18.16%
|
-
|
|
Jan 01
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
10,908
-5.56%
|
$621,756
$57.81 P/Share
|
|
Jan 01
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
21,799
+10.01%
|
-
|
|
Jan 01
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
40,104
-2.51%
|
$2,285,928
$57.81 P/Share
|
|
Jan 01
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
95,919
+5.67%
|
-
|
|
Jan 01
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
5,508
-7.44%
|
$313,956
$57.81 P/Share
|
|
Jan 01
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
17,439
+19.07%
|
-
|
|
Jan 01
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
3,729
-8.37%
|
$212,553
$57.81 P/Share
|
|
Jan 01
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
7,848
+14.98%
|
-
|
|
Jan 01
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
7,573
-29.88%
|
$431,661
$57.81 P/Share
|
|
Jan 01
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
13,080
+34.04%
|
-
|